Zobrazeno 1 - 10
of 67
pro vyhledávání: '"PO Gunnarsson"'
Publikováno v:
International journal of oncology. 5(2)
The cytotoxic effect of estramustine-phosphate (EMP) and the uptake in tumor tissue were investigated in a rat glioma model in vitro and in vivo. EMP, a combination of nornitrogen mustard and 17beta-estradiol, is a cytotoxic drug which main target is
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::7a241cad1ee93a51cb266a954374102a
https://pubmed.ncbi.nlm.nih.gov/21559588
https://pubmed.ncbi.nlm.nih.gov/21559588
Publikováno v:
Effects of Nicotine on Biological Systems ISBN: 9783034874595
Using a capillary gas chromatographic method, plasma levels of nicotine was monitored after intranasal administration of nicotine to rats and humans. In the first study nicotine was administered intranasally to rats and a pH-dependent absorption was
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::2f1635a516d1e675ff9006749b903de5
https://doi.org/10.1007/978-3-0348-7457-1_8
https://doi.org/10.1007/978-3-0348-7457-1_8
Publikováno v:
British Journal of Clinical Pharmacology. 16:760-761
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::5eeb6422808423d00c0a1d5618ead793
https://doi.org/10.1111/j.1365-2125.1983.tb02263.x
https://doi.org/10.1111/j.1365-2125.1983.tb02263.x
Autor:
Seidegård J; Department of Preclinical Development, Active Biotech Research AB, P.O. Box 724, 220 07 Lund, Sweden., Grönquist L, Tuvesson H, Gunnarsson PO
Publikováno v:
In vitro cellular & developmental biology. Animal [In Vitro Cell Dev Biol Anim] 2009 Jan-Feb; Vol. 45 (1-2), pp. 32-4. Date of Electronic Publication: 2008 Oct 15.
Autor:
Sennbro CJ; Research and Development Laboratories, Active Biotech Research AB, Box 724, SE-22007 Lund, Sweden. carl-johan.sennbro@activebiotech.com, Olin M, Edman K, Hansson G, Gunnarsson PO, Svensson LD
Publikováno v:
Rapid communications in mass spectrometry : RCM [Rapid Commun Mass Spectrom] 2006; Vol. 20 (22), pp. 3313-8.
Autor:
Tuvesson H; Preclinical Development, Active Biotech Research AB, Box 724, SE-220 07 Lund, Sweden. helen.tuvesson@activebiotech.com, Hallin I, Persson R, Sparre B, Gunnarsson PO, Seidegård J
Publikováno v:
Drug metabolism and disposition: the biological fate of chemicals [Drug Metab Dispos] 2005 Jun; Vol. 33 (6), pp. 866-72. Date of Electronic Publication: 2005 Mar 11.
Autor:
Tuvesson H; Preclinical Development, Active Biotech Research AB, SE-220 07 Lund, Sweden. helen.tuvesson@ativebiotech.com, Hallin I, Ellman M, Sparre B, Gunnarsson PO, Seidegård J
Publikováno v:
Xenobiotica; the fate of foreign compounds in biological systems [Xenobiotica] 2005 Mar; Vol. 35 (3), pp. 293-304.
Autor:
Edman K; Active Biotech Research AB, Box 724, S-220 07 Lund, Sweden. karin.edman@lrc.activebiotech.com, Eriksson B, Svensson L, Gunnarsson PO
Publikováno v:
Journal of chromatography. B, Analytical technologies in the biomedical and life sciences [J Chromatogr B Analyt Technol Biomed Life Sci] 2003 Mar 05; Vol. 785 (2), pp. 311-6.
Autor:
Hudes G; Department of Medical Oncology, Fox Chase Cancer Center, Philadelphia, PA 19111, USA. g_hudes@fccc.edu, Haas N, Yeslow G, Gillon T, Gunnarsson PO, Ellman M, Nordle O, Eriksson B, Miller L, Cisar L, Kopreski M, Viaro D, Hartley-Asp B
Publikováno v:
Journal of clinical oncology : official journal of the American Society of Clinical Oncology [J Clin Oncol] 2002 Feb 15; Vol. 20 (4), pp. 1115-27.
Autor:
Tuvesson H; Pharmacokinetics and Metabolism, Active Biotech Research AB, Lund, Sweden. helen.tuvesson@activebiotech.com, Wienkers LC, Gunnarsson PO, Seidegård J, Persson R
Publikováno v:
Xenobiotica; the fate of foreign compounds in biological systems [Xenobiotica] 2000 Sep; Vol. 30 (9), pp. 905-14.